These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 34597175)
1. Could 675-nm Laser Treatment Be Effective for Facial Melasma Even in Darker Phototype? Bonan P; Verdelli A; Pieri L; Fusco I Photobiomodul Photomed Laser Surg; 2021 Oct; 39(10):634-636. PubMed ID: 34597175 [No Abstract] [Full Text] [Related]
2. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study. Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866 [TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser. Geddes ER; Stout AB; Friedman PM Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994 [TBL] [Abstract][Full Text] [Related]
4. A New 675 nm Laser Device in the Treatment of Melasma: Results of a Prospective Observational Study. Nisticò SP; Tolone M; Zingoni T; Tamburi F; Scali E; Bennardo L; Cannarozzo G Photobiomodul Photomed Laser Surg; 2020 Sep; 38(9):560-564. PubMed ID: 32833576 [No Abstract] [Full Text] [Related]
5. Therapeutic outcome of melasma treatment by dual-wavelength (511 and 578 nm) laser in patients with skin phototypes III-V. Eimpunth S; Wanitphakdeedecha R; Triwongwaranat D; Varothai S; Manuskiatti W Clin Exp Dermatol; 2014 Apr; 39(3):292-7. PubMed ID: 24635063 [TBL] [Abstract][Full Text] [Related]
6. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser. Alsaad SM; Ross EV; Mishra V; Miller L Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141 [TBL] [Abstract][Full Text] [Related]
7. A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman's formulation in patients with melasma in darker skin. Dev T; Sreenivas V; Sharma VK; Sahni K; Bhari N; Sethuraman G Int J Dermatol; 2020 Dec; 59(12):1525-1530. PubMed ID: 33017045 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of 1927 nm fractional Thulium fiber laser for the treatment of melasma: a retrospective study of 100 patients. Kurmuş G; Tatlıparmak A; Aksoy B; Koç E; Aşiran Serdar Z; Ergin C J Cosmet Laser Ther; 2019; 21(7-8):408-411. PubMed ID: 31690148 [No Abstract] [Full Text] [Related]
9. The 675-nm wavelength for treating facial melasma. Coricciati L; Gabellone M; Donne PD; Pennati BM; Zingoni T Skin Res Technol; 2023 Aug; 29(8):e13434. PubMed ID: 37632189 [TBL] [Abstract][Full Text] [Related]
10. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective? Gokalp H; Akkaya AD; Oram Y J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828 [TBL] [Abstract][Full Text] [Related]
11. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301 [TBL] [Abstract][Full Text] [Related]
12. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma. Chalermchai T; Rummaneethorn P J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467 [TBL] [Abstract][Full Text] [Related]
13. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV. Brown AS; Hussain M; Goldberg DJ J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660 [TBL] [Abstract][Full Text] [Related]
14. Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma. Choi M; Choi JW; Lee SY; Choi SY; Park HJ; Park KC; Youn SW; Huh CH J Dermatolog Treat; 2010 Jul; 21(4):224-8. PubMed ID: 20509814 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma. Zhou X; Gold MH; Lu Z; Li Y Dermatol Surg; 2011 Jul; 37(7):962-70. PubMed ID: 21615824 [TBL] [Abstract][Full Text] [Related]
16. Treatment of melasma with the 1,927-nm fractional thulium fiber laser: a retrospective analysis of 20 cases with long-term follow-up. Niwa Massaki AB; Eimpunth S; Fabi SG; Guiha I; Groff W; Fitzpatrick R Lasers Surg Med; 2013 Feb; 45(2):95-101. PubMed ID: 23255085 [TBL] [Abstract][Full Text] [Related]
17. A Randomized, Controlled, Split-Face Study of the Efficacy of a Picosecond Laser in the Treatment of Melasma. Lyons AB; Moy RL; Herrmann JL J Drugs Dermatol; 2019 Nov; 18(11):1104-1107. PubMed ID: 31741350 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients. Jang WS; Lee CK; Kim BJ; Kim MN Dermatol Surg; 2011 Aug; 37(8):1133-40. PubMed ID: 21585597 [TBL] [Abstract][Full Text] [Related]
19. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma. Ustuner P; Balevi A; Ozdemir M J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378 [TBL] [Abstract][Full Text] [Related]
20. Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment. Gao YL; Jia XX; Wang M; Hua Y; Zheng H; Xiang WZ; Song XZ Lasers Med Sci; 2019 Jun; 34(4):767-771. PubMed ID: 30302596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]